From: A weighted and integrated drug-target interactome: drug repurposing for schizophrenia as a use case
 |  | Overlap (numbera/proportionb) | |||||
---|---|---|---|---|---|---|---|
 | Source | DrugBank | KEGG | TTD | MATADOR | PDSP | BindingDB |
Drug | DrugBank | 4,316 | 0.679 | 0.369 | 0.590 | 0.045 | 0.269 |
 | KEGG | 761 | 1,121 | 0.467 | 0.550 | 0.135 | 0.231 |
 | TTD | 1,594 | 524 | 14,073 | 0.405 | 0.069 | 0.425 |
 | MATADOR | 447 | 417 | 307 | 758 | 0.199 | 0.170 |
 | PDSP | 195 | 151 | 340 | 151 | 4,947 | 0.004 |
 | BindingDB | 1,162 | 259 | 5,984 | 129 | 22 | 290,874 |
Target | DrugBank | 2,102 | 0.622 | 0.510 | 0.108 | 0.324 | 0.182 |
 | KEGG | 295 | 474 | 0.418 | 0.409 | 0.283 | 0.348 |
 | TTD | 479 | 198 | 940 | 0.113 | 0.434 | 0.526 |
 | MATADOR | 198 | 194 | 106 | 1,840 | 0.262 | 0.040 |
 | PDSP | 47 | 41 | 63 | 38 | 145 | 0.152 |
 | BindingDB | 372 | 165 | 494 | 73 | 22 | 2,048 |
Drug-target | DrugBank | 9,886 | 0.440 | 0.200 | 0.092 | 0.039 | 0.149 |
 | KEGG | 1,553 | 3,532 | 0.166 | 0.254 | 0.067 | 0.117 |
 | TTD | 1,976 | 586 | 22,791 | 0.032 | 0.042 | 0.386 |
 | MATADOR | 906 | 898 | 341 | 10,687 | 0.023 | 0.017 |
 | PDSP | 384 | 237 | 490 | 247 | 11,762 | 0.007 |
 | BindingDB | 1,471 | 415 | 8,804 | 179 | 81 | 503,378 |